Rankings
▼
Calendar
PASG Q1 2020 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$28M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-10.14
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$392M
Total Liabilities
$6M
Stockholders' Equity
$387M
Cash & Equivalents
$367M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$4M
-327.8%
Net Income
-$18M
-$8M
-129.3%
← FY 2020
All Quarters
Q2 2020 →